Referral to palliative care services in the last 3 months of life of hospitalised patients with different haematological malignancies
| Total study population | Acute leukaemia | Chronic lymphoid leukaemia | Chronic myeloid leukaemia | Hodgkin’s lymphoma | Multiple myeloma | Myelodysplastic syndromes | Non-Hodgkin’s lymphoma | |
| n=46 629 | n=11 531 | n=4161 | n=1157 | n=1022 | n=8803 | n=6693 | n=13 262 | |
| n (%)* | n (%)* | n (%)* | n (%)* | n (%)* | n (%)* | n (%)* | n (%)* | |
| Reporting of palliative status† | ||||||||
| 30 days before death | 6916 (14.8) | 1832 (15.9) | 455 (10.9) | 155 (13.4) | 144 (14.1) | 1276 (14.5) | 741 (11.1) | 2314 (17.5) |
| 15 before death | 12 312 (26.4) | 3249 (28.2) | 831 (20.0) | 251 (21.7) | 278 (27.2) | 2403 (27.3) | 1319 (19.7) | 3982 (30.0) |
| 7 days before death | 16 884 (36.2) | 4588 (39.8) | 1139 (27.4) | 342 (29.5) | 353 (34.5) | 3302 (37.5) | 1842 (27.5) | 5319 (40.1) |
| Day of death | 21 863 (46.9) | 6119 (53.1) | 1520 (36.5) | 447 (38.6) | 430 (42.0) | 4320 (49.1) | 2380 (35.6) | 6650 (50.1) |
| Palliative status was not reported‡ | 24 766 (53.1) | 5413 (46.9) | 2641 (63.5) | 711 (61.4) | 593 (58.0) | 4484 (50.9) | 4313 (64.4) | 6612 (49.9) |
| Inpatient palliative care unit | ||||||||
| Admission | 2799 (6.0) | 772 (6.7) | 146 (3.5) | 61 (5.3) | 42 (4.1) | 551 (6.3) | 295 (4.4) | 930 (7.0) |
| Death | 2583 (5.5) | 722 (6.3) | 137 (3.3) | 59 (5.1) | 35 (3.4) | 509 (5.8) | 277 (4.1) | 845 (6.4) |
| Palliative care support bed | ||||||||
| Admission | 5843 (12.5) | 1607 (13.9) | 410 (9.9) | 98 (8.5) | 117 (11.4) | 1183 (13.4) | 511 (7.6) | 1917 (14.5) |
| Death | 4939 (11.9) | 1356 (12.8) | 340 (9.1) | 78 (7.8) | 97 (10.8) | 997 (12.9) | 453 (7.6) | 1618 (14.1) |
*Sex-standardised and age-standardised values, using the total study population as reference.
†Cumulative percentage.
‡During the last 3 months of life.